GOLUFSA Trademark

Trademark Overview


On Monday, June 9, 2014, a trademark application was filed for GOLUFSA with the United States Patent and Trademark Office. The USPTO has given the GOLUFSA trademark a serial number of 86303624. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 25, 2022. This trademark is owned by Glaxo Group Limited. The GOLUFSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
golufsa

General Information


Serial Number86303624
Word MarkGOLUFSA
Filing DateMonday, June 9, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 25, 2022
Registration Number4788494
Registration DateTuesday, August 11, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkGOLF USA

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, February 25, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, August 11, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 11, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 20, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 2, 2015ASSIGNED TO LIE
Friday, March 27, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 23, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 23, 2015INQUIRY TO SUSPENSION E-MAILED
Monday, March 23, 2015SUSPENSION INQUIRY WRITTEN
Tuesday, September 23, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 23, 2014LETTER OF SUSPENSION E-MAILED
Tuesday, September 23, 2014SUSPENSION LETTER WRITTEN
Thursday, September 18, 2014ASSIGNED TO EXAMINER
Monday, June 30, 2014TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, June 30, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, June 20, 2014NOTICE OF PSEUDO MARK E-MAILED
Thursday, June 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 12, 2014NEW APPLICATION ENTERED IN TRAM